|
1
|
Reya T, Morrison SJ, Clarke MF and
Weissman IL: Stem cells, cancer, and cancer stem cells. Nature.
414:105–111. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Dalerba P, Cho RW and Clarke MF: Cancer
stem cells: models and concepts. Annu Rev Med. 58:267–284. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ricci-Vitiani L, Lombardi DG, Pilozzi E,
et al: Identification and expansion of human
colon-cancer-initiating cells. Nature. 445:111–115. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Smalley MJ and Dale TC: Wnt signalling in
mammalian development and cancer. Cancer Metastasis Rev.
18:215–230. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dontu G, Jackson KW, McNicholas E,
Kawamura MJ, Abdallah WM and Wicha MS: Role of Notch signaling in
cell-fate determination of human mammary stem/progenitor cells.
Breast Cancer Res. 6:R605–R615. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liu S, Dontu G, Mantle ID, et al: Hedgehog
signaling and Bmi-1 regulate self-renewal of normal and malignant
human mammary stem cells. Cancer Res. 66:6063–6071. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bose D, Zimmerman LJ, Pierobon M, et al:
Chemoresistant colorectal cancer cells and cancer stem cells
mediate growth and survival of bystander cells. Br J Cancer.
105:1759–1767. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Eyler CE and Rich JN: Survival of the
fittest: cancer stem cells in therapeutic resistance and
angiogenesis. J Clin Oncol. 26:2839–2845. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rich JN and Bao S: Chemotherapy and cancer
stem cells. Cell Stem Cell. 1:353–355. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang K, Liu L, Zhang T, Zhu YL, Qiu F, Wu
XG, Wang XL, Hu FQ and Huang J: Oxaliplatin-incorporating micelles
eliminate both cancer stem-like and bulk cell populations in
colorectal cancer. Int J Nanomedicine. 6:3207–3218. 2011.PubMed/NCBI
|
|
11
|
Todaro M, Alea MP, Di Stefano AB, et al:
Colon cancer stem cells dictate tumor growth and resist cell death
by production of interleukin-4. Cell Stem Cell. 1:389–402. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li Y, Zhang T, Korkaya H, et al:
Sulforaphane, a dietary component of broccoli/broccoli sprouts,
inhibits breast cancer stem cells. Clin Cancer Res. 16:2580–2590.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yu Y, Kanwar SS, Patel BB, Nautiyal J,
Sarkar FH and Majumdar AP: Elimination of colon cancer stem-like
cells by the combination of curcumin and FOLFOX. Transl Oncol.
2:321–328. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li Y, Wicha MS, Schwartz SJ and Sun D:
Implications of cancer stem cell theory for cancer chemoprevention
by natural dietary compounds. J Nutr Biochem. 22:799–806. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li LX, Ye SL, Wang YH and Tang ZZ:
Progress on experimental research and clinical application of
Trametes robiniophila. Bulletin of Chinese Cancer.
16:110–113. 2007.
|
|
16
|
Zhang N, Kong X, Yan S, Yuan C and Yang Q:
Huaier aqueous extract inhibits proliferation of breast cancer
cells by inducing apoptosis. Cancer Sci. 101:2375–2383. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Guo Y, Cheng P, Chen Y, et al: Isolation
and analysis of the polysaccharide of Huaier mycelium. Chin J
Biochem Pharm. 63:56–59. 1993.
|
|
18
|
Ren J, Zheng C, Feng G, et al: Inhibitory
effect of extract of fungi of Huaier on hepatocellular carcinoma
cells. J Huazhong Univ Sci Technolog Med Sci. 29:198–201. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xu X, Wei Q, Wang K, et al: Anticancer
effects of Huaier are associated with down-regulation of P53. Asian
Pac J Cancer Prev. 12:2251–2254. 2011.PubMed/NCBI
|
|
20
|
Clevers H: Wnt/beta-catenin signaling in
development and disease. Cell. 127:469–480. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Dontu G, Abdallah WM, Foley JM, et al: In
vitro propagation and transcriptional profiling of human mammary
stem/progenitor cells. Genes Dev. 17:1253–1270. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lin SY, Xia W, Wang JC, et al:
Beta-catenin, a novel prognostic marker for breast cancer: its
roles in cyclin D1 expression and cancer progression. Proc Natl
Acad Sci USA. 97:4262–4266. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Takahashi-Yanaga F and Sasaguri T: GSK-3β
regulates cyclin D1 expression: a new target for chemotherapy. Cell
Signal. 20:581–589. 2008.
|
|
24
|
Dean M, Fojo T and Bates S: Tumour stem
cells and drug resistance. Nat Rev Cancer. 5:275–284. 2005.
View Article : Google Scholar
|
|
25
|
Nicolini A, Ferrari P, Fini M, et al: Stem
cells: their role in breast cancer development and resistance to
treatment. Curr Pharm Biotechnol. 12:196–205. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang K, Zhang T, Liu L, et al: Novel
micelle formulation of curcumin for enhancing antitumor activity
and inhibiting colorectal cancer stem cells. Int J Nanomedicine.
7:4487–4497. 2012.PubMed/NCBI
|
|
27
|
Shenoy A, Butterworth E and Huang EH: ALDH
as a marker for enriching tumorigenic human colonic stem cells.
Methods Mol Biol. 916:373–85. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Huang W, Yuan LN, Wu H, Yang JY, Wang WT
and Xu MQ: Retrospective cohort study on clinical value of Huaier
granule in postoperative patients with liver transplantation for
hepato-cellular carcinoma. Chinese Journal of Bases and Clinics in
General Surgery. 17:547–551. 2010.
|
|
29
|
Vogler T, Kriegl L, Horst D, et al: The
expression pattern of aldehyde dehydrogenase 1 (ALDH1) is an
independent prognostic marker for low survival in colorectal
tumors. Exp Mol Pathol. 92:111–117. 2012. View Article : Google Scholar
|
|
30
|
Ginestier C, Hur MH, Charafe-Jauffret E,
et al: ALDH1 is a marker of normal and malignant human mammary stem
cells and a predictor of poor clinical outcome. Cell Stem Cell.
1:555–567. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Huang EH, Hynes MJ, Zhang T, et al:
Aldehyde dehydrogenase 1 is a marker for normal and malignant human
colonic stem cells (SC) and tracks SC overpopulation during colon
tumorigenesis. Cancer Res. 69:3382–3389. 2009. View Article : Google Scholar
|
|
32
|
Chen Y, Orlicky DJ, Matsumoto A, Singh S,
Thompson DC and Vasiliou V: Aldehyde dehydrogenase 1B1 (ALDH1B1) is
a potential biomarker for human colon cancer. Biochem Biophys Res
Commun. 405:173–179. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Cammareri P, Lombardo Y, Francipane MG,
Bonventre S, Todaro M and Stassi G: Isolation and culture of colon
cancer stem cells. Methods Cell Biol. 86:311–324. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Fan X, Ouyang N, Teng H and Yao H:
Isolation and characterization of spheroid cells from the HT29
colon cancer cell line. Int J Colorectal Dis. 26:1279–1285. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Vermeulen L, De Sousa E, Melo F, van der
Heijden M, et al: Wnt activity defines colon cancer stem cells and
is regulated by the microenvironment. Nat Cell Biol. 12:468–476.
2010. View
Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wang X, Zhang N, Huo Q and Yang Q:
Anti-angiogenic and antitumor activities of Huaier aqueous extract.
Oncol Rep. 28:1167–1175. 2012.PubMed/NCBI
|
